Skip to content

A trial to learn if itraconazole and carbamazepine affect how AZD5462 moves throughout the bodies of healthy adults

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-519834-21-00
Acronym
AZD5462-D9090C00012
Enrollment
42
Registered
2025-04-22
Start date
Unknown
Completion date
2025-07-14
Last updated
2025-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Heart Failure

Interventions

None listed

Sponsors

AstraZeneca AB
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Germany

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026